Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inductively Coupled Plasma Atomic Emission Spectroscopy: Principle

Inductively Coupled Plasma Atomic Emission Spectroscopy: Principle

Inductively coupled plasma (ICP) is the most widely used plasma source in atomic emission spectroscopy (AES), also known as Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES). The ICP source, or torch, consists of three concentric quartz tubes with argon gas flowing through them. A spark from a Tesla coil initiates the ionization of argon, generating a high-temperature plasma.
The ions and electrons produced interact with the fluctuating magnetic field created by a water-cooled...

Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview

Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview

In inductively coupled plasma–mass spectrometry (ICP–MS), an inductively coupled plasma (ICP) torch is used as an atomizer and ionizer. Solid samples are dissolved and volatilized before being introduced into the high-temperature argon plasma, while solution samples are nebulized and passed through the high-temperature argon plasma. Plasma dissociates the analytes and ionizes their component atoms to form a mixture of positive ions and molecular species. The positive ions are then passed on to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inverse design and discovery of high entropy alloy catalysts for efficient oxygen evolution reaction.

The Journal of chemical physics·2026

Same author

Reliability of Singh's Index and Calcaneal Index in Assessing Osteoporosis Compared with Quantitative Ultrasound Bone Mineral Density.

Journal of orthopaedic case reports·2026

Same author

Immunohistochemical Expression of Vimentin in Breast Carcinoma and Its Correlation With Histopathological Prognostic Factors.

Cureus·2026

Same author

Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations.

The oncologist·2026

Same author

Optimizing cervical cancer diagnosis with a hybrid deep neural network and progressive resizing on pap smear WSIs.

Scientific reports·2026

Same author

Nanomedicine-Based Approaches for Therapeutic Delivery Across the Blood-Brain Barrier in Neurological Disorders.

Current pharmaceutical design·2026

Search research articles

Related Experiment Video

Updated: May 29, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

IgA plasma cell leukemia.

Tejinder Singh¹, Cs Premalata, Kv Sajeevan

¹Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Dr. M. H. Marigowda Road, Bangalore-560 029, India.

Journal of Laboratory Physicians

|September 23, 2011

Summary

Plasma cell leukemia (PCL) is a rare cancer. This report details a rare IgA primary PCL case with poor treatment response, highlighting the need for better therapeutic strategies.

Keywords:

Primary plasma cell leukemia multiple myeloma plasma cell dyscrasia

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Related Experiment Videos

Last Updated: May 29, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Area of Science:

Hematology
Oncology

Background:

Plasma cell leukemia (PCL) is a rare hematologic malignancy, representing 1-2% of multiple myeloma (MM) cases.
PCL presents in two forms: primary (de novo) with acute leukemic phase or secondary, as an advanced stage of MM.
Median age at diagnosis is over 50 years, with monoclonal protein typically being IgG or IgA.

Observation:

This case report describes a rare instance of IgA primary PCL, a de novo presentation without prior MM.
The patient, diagnosed with IgA primary PCL, received combination chemotherapy (vincristine, adriamycin, dexamethasone).

Findings:

The patient exhibited a poor response to the standard combination therapy.
The patient unfortunately passed away three months post-diagnosis.

Implications:

This case underscores the aggressive nature of IgA primary PCL.
Highlights the urgent need for novel therapeutic approaches for rare PCL subtypes.
Emphasizes the importance of early diagnosis and tailored treatment strategies for PCL patients.